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The yeast Cdc7 function is required for the G1/S transition and is dependent on passage
through START, a point controlled by the Cdc28/cdc2/p34 protein kinase. CDC7 encodes
a protein kinase activity, and we now show that this kinase activity varies in the cell cycle
but that protein levels appear to remain constant. We present several lines of evidence that
periodic activation of CDC7 kinase is at least in part through phosphorylation. First, the
kinase activity of the Cdc7 protein is destroyed by dephosphorylation of the protein in
vitro with phosphatase. Second, Cdc7 protein is hypophosphorylated and inactive as a
kinase in extracts of cells arrested at START but becomes active and maximally phos-
phorylated subsequent to passage through START. The phosphorylation pattern of Cdc7
protein is complex. Phosphopeptide mapping reveals four phosphopeptides in Cdc7 pre-
pared from asynchronous yeast cells. Both autophosphorylation and phosphorylation in
trans appear to contribute to this pattern. Autophosphorylation is shown to occur by using
a thermolabile Cdc7 protein. A protein in yeast extracts can phosphorylate and activate
Cdc7 protein made in Escherichia coli, and phosphorylation is thermolabile in cdc28 mutant
extracts. Cdc7 protein carrying a serine to alanine change in the consensus recognition site
for Cdc28 kinase shows an altered phosphopeptide map, suggesting that this site is im-
portant in determining the overall Cdc7 phosphorylation pattern.
INTRODUCTION
The eukaryotic cell cycle is composed of two major
events, S phase, during which the chromosomes are
replicated, and M phase, during which the chromo-
somes are segregated. These two portions of the cycle
are separated by gaps called Gl and G2, which are de-
voted to regulating the transitions between replication
and segregation. During G1, the events leading to chro-
mosome duplication are monitored and executed.
Checkpoints ensuring completion of DNA synthesis and
readiness for nuclear division occur in G2 (Hartwell and
Weinert, 1989). In the past few years, significant break-
throughs have been made in determining the molecular
events that regulate and promote entry into M phase
(Dunphy and Newport, 1988a; Lewin, 1990). A key
regulatory molecule in this process is highly conserved
in eukaryotes, namely, the p34/cdc2+/MPF (mitosis
promoting factor) protein kinase subunit (Dunphy and
Newport, 1988b). Because much less is known about
the events leading to the initiation of nuclear DNA rep-
lication at the G1/S transition, we have undertaken
studies of this phase of the cell cycle.
In unicellular organisms such as yeast (Saccharomyces
cerevisiae, Schizosaccharomyces pombe), the major control
point in Gl is called START, which may or may not
correspond to the "restriction point" in mammalian cells
(Pringle and Hartwell, 1981; Pardee, 1989). START de-
fines the point in the cycle after which the cell is com-
mitted to a round of DNA synthesis and no longer can
undergo the alternative developmental program of
conjugation. Several yeast mutants, the best studied of
which is cdc28, arrest at a point in Gl at which conju-
gation is still possible and thus are said to affect START
(Reed, 1980; Pringle and Hartwell, 1981). CDC28 en-
codes the homolog of the p34/cdc2+/MPF protein ki-
nase subunit (Reed and Wittenberg, 1990). Thus it ap-
pears that the same protein kinase is involved in
regulating both the Gl/S and G2/M transitions during
the yeast cell cycle (Nurse and Bissett, 1981; Piggott et
al., 1982; Ghiara et al., 1991; Surana et al., 1991).
We have very little information on the molecular na-
ture of the events set in motion by CDC28 and the other
START genes. Although the commitment to DNA syn-
thesis is made by passage through START, DNA syn-
thesis does not begin immediately. A number of addi-
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tional genetically defined steps must occur before the
onset of DNA replication. It is likely that both induction
of the genes encoding replication proteins and post-
translational activation of replication proteins are pre-
conditions for the initiation of DNA synthesis. The
CDC28, CDC4, and CDC7 genes are thought to define
one series of steps that must be completed before the
initiation of DNA synthesis (Hartwell, 1976; Pringle and
Hartwell, 1981). CDC28 encodes a protein kinase, CDC4
encodes a protein with homology to the b-subunit of
transducin and the ets oncogene (Peterson et al., 1984;
Fong et al., 1986) and CDC7 encodes a protein kinase
(Patterson et al., 1986; Hollingsworth and Sclafani,
1990; Yoon and Campbell, 1991). Though these activ-
ities suggest a signal transduction cascade, little infor-
mation is available about their functional interrelation-
ships.
Our focus has been to determine the biochemical basis
for the position of the Cdc7 protein in the putative Gl
regulatory cascade. The CDC7 controlled events have
been shown genetically to depend on completion of
START, because the CDC7 step cannot be completed
during block of cells with the mating pheromone a-
factor, which like cdc28 mutations, arrests cells at START
(Hereford and Hartwell, 1974). The Cdc7 protein is
thought to execute its function late in Gl, since cells
carrying a thermosensitive (ts) cdc7 mutation arrest mi-
totic growth at the Gl/S phase boundary at the restric-
tive temperature, just before the initiation of DNA syn-
thesis (Hartwell, 1973, 1976). These cells show a
dumbbell shaped terminal phenotype typically asso-
ciated with a DNA synthesis or nuclear division defect
(Hartwell, 1973). Another reason for placing CDC7
function very late in Gl is the fact that cdc28 and cdc4
mutants blocked at the nonpermissive temperature and
then returned to the permissive temperature in the
presence of the protein synthesis inhibitor cyclohexi-
mide do not progress further through the cycle and do
not enter S phase, whereas cdc7 mutants treated in the
same way enter S phase and complete DNA synthesis
in the presence of protein synthesis inhibitors (Hereford
and Hartwell, 1974). Further protein synthesis is thus
necessary for the initiation of DNA synthesis after
CDC28 and CDC4, whereas all of the proteins essential
for DNA replication appear to be present at the CDC7
stage. The crucial proteins required have not yet been
identified, but the cyclins are likely to be among them
(Wittenberg et al., 1990). CDC7 thus mimics the final
stage of the "restriction point" in mammalian cells, in-
sofar as it was defined as the point in the cell cycle after
which no further protein synthesis is necessary for ini-
tiation of DNA synthesis. Thus CDC7 may define a sec-
ond, post-START commitment point in the yeast cell
cycle. Evidence suggesting the presence of Cdc7 protein
in a putative DNA replication complex has been pre-
sented (Jazwinski, 1988).
-In contrast to this behavior during mitosis, diploid
homozygous cdc7-ts cells (like cdc28-ts) initiate pre-
meiotic DNA synthesis normally at the restrictive tem-
perature. However, these diploids do not form a
synaptonemal complex, nor do they commit to recom-
bination or form ascospores, indicating that the cdc7
lesion affects the mitotic and meiotic pathways in a dif-
ferent, distinct manner (Schild and Byers, 1978). Fur-
thermore, the CDC7 gene has also been implicated in
an error-prone DNA repair pathway as a member of
the RAD6 epistasis group (Njagi and Kilbey, 1982). Fi-
nally, Cdc7 may also be involved in transcriptional si-
lencing of the mating type cassette right (HMR) (Axelrod
and Rine, 1991).
At present, little is known about how Cdc7 affects
these different DNA processes. A clue as to the molec-
ular function of Cdc7 was afforded by the demonstra-
tion that the open reading frame encoding CDC7 con-
tains the 11 catalytic domains characteristic of protein
kinases (Patterson et al., 1986). We and others have
shown that the Cdc7 protein isolated from vegetatively
growing yeast cells is active as a kinase that phosphor-
ylates histone Hi in vitro (Hollingsworth and Sclafani,
1990; Yoon and Campbell, 1991). Two groups have
shown by site-directed mutagenesis that Lys 76, which
corresponds to the conserved lysine residue found in
the ATP binding domain of all protein kinases, is es-
sential for in vivo function, arguing that the kinase ac-
tivity of Cdc7 is essential for its function in mitosis and
meiosis (Buck et al., 1991; Hollingsworth et al., 1992).
In addition, the Cdc7 protein is modified by phosphor-
ylation and is located in the nucleus (Yoon and Camp-
bell, 1991). The demonstration that Cdc7 is a protein
kinase associated with the nuclei of mitotic cells suggests
that Cdc7 may function in the mitotic cell cycle by
phosphorylating pr6teins involved in the initiation of
DNA synthesis and/or in the G1/S transition. Recently,
Din et al. (1990) have shown that both CDC28 and CDC7
are required in vivo for phosphorylation of the 34 kDa
subunit of the replication protein RP-A, and that this
phosphorylation occurs at the Gl/S transition. RP-A
was originally isolated from human cells in the process
of fractionating cellular extracts into components ca-
pable of reconstituting SV40 DNA replication in vitro
(Wobbe et al., 1987; Fairman and Stillman, 1988; Wold
and Kelly, 1988). RP-A is single stranded DNA binding
(SSB) protein, essential for both the initiation and elon-
gation reactions (Wold and Kelly, 1988; Kenny et al.,
1989, 1990). Because of its documented cell cycle specific
phosphorylation pattern, RP-A is a good candidate for
direct phosphorylation by either the Cdc28 or Cdc7 ki-
nase, although there may be others as well.
Although we had some clues to the role of CDC7
from previous work, very few clues were available as
to what limits CDC7 function to a specific point in the
cell cycle. CDC7 is not periodically transcribed, and cells
carrying a deletion of CDC7 on the chromosome can
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divide up to eight times after loss of a plasmid carrying
the CDC7 gene (Sclafani et al., 1988). Thus periodic ac-
tivation of Cdc7 kinase rather than abundance may
govern its stage-specific function. Other protein kinases
are known to be regulated by association with regulatory
subunits and/or phosphorylation. In this work we
present evidence that Cdc7 function is, at least in part,
regulated by phosphorylation.
MATERIALS AND METHODS
Strains, Media, and Plasmids
The genotypes and sources of the yeast strains used were SEY6210,
a his3, leu2, lys2, suc2, trpl, and ura3 (S.D. Emr, California Institute
of Technology); YC7379, a adel, his7, lys2, tyrl, ura3, and cdc7-A (Yoon
and Campbell, 1991); CU4-1, a adel, ura3, and cdc4-1 (A.Y. Jong,
University of Southern California); USC6-5, a leu2, ura3, and cdc6-1
(A.Y. Jong, University of Southern California); YC488m, a hisl, leu2,
poll-17, trpl, ura3, and canl (M. Budd, California Institute of Tech-
nology); YC28, a adel, his3, ura3, and cdc28-13 (this work); G1906c,
a barl-1, leul, rmel, trp5, ura3, canl, and cir+ (A.Y. Jong, University
of Southern California). Cells were routinely grown in yeast extract,
peptone, dextrose (YPD) medium (1% yeast extract, 2% Bacto peptone,
2% glucose) or synthetic minimal medium supplemented with amino
acids and adenine but lacking uracil. Either 2% glucose, or 2% raffi-
nose, plus 2% galactose were used as the carbon source. For in vivo
32Pi labeling, cells were grown in LPSM medium (Reneke et al., 1988).
Escherichia coli cells were grown in 1% bacto tryptone, 0.5% bacto
yeast extract, and 1% NaCl (LB) medium containing ampicillin (50
Ag/ml). To overexpress wild-type CDC7, thermolabile cdc7-1, and the
CDC7-hemagglutinin fusion gene in yeast, we used a high copy num-
ber, 2 ,um containing vector pSEY18-Gal (S.D. Emr). pSEY18-Gal also
contains the URA3 gene and the inducible GALI,10 promoter. pSYC758
carries wild-type CDC7 under the GALIO promoter of pSEY18-Gal
(Yoon and Campbell, 1991). pSYC7-158, carries a temperature sen-
sitive cdc7-1 gene under the GAL1,10 promoter, and was constructed
for this work as explained in detail below. pSYCHA7 carries the CDC7-
hemagglutinin epitope fusion gene under the control of the GALl,1O
promoter (see below for details). The T7 promoter containing vector,
pT7-7 (Tabor and Richardson, 1985), was used to express the Cdc7-
hemagglutinin epitope fusion protein in E. coli. Plasmid pSYC7-83
carries a cdc7 mutant allele with a Ser 83 to Ala change cloned in
pSEY18-Gal exactly as in pSYC758.
Buffers and Inhibitors
The buffers and inhibitors used were the following: C buffer: 50 mM
tris(hydroxymethyl)aminomethane (Tris), pH 7.5, 150 mM NaCl, 15%
sucrose; IP buffer (immunoprecipitation buffer), 50 mM Tris-HCl at
pH 7.5, 150 mM NaCl, 0.5% Tween 20, 0.2 mM EDTA, and protease
inhibitors; K buffer (kinase buffer), 25 mM Tris-HCl at pH 7.5, 5 mM
NaF, 15 mM MgCl2, 5 mM ethylene glycol-bis(Ql-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA), and protease inhibitors; L buffer
(lysis buffer), 100 mM N-2-hydroxyethylpiperazine-N'-2-ethanesul-
fonic acid (HEPES) at pH 7.9, 0.5% sodium deoxycholate, 0.5% Triton
X-100, 0.1% sodium dodecyl sulfate (SDS), 0.2 mM EDTA, 0.2 mM
EGTA, 2.5 mM dithiothreitol, protease inhibitors, and phosphatase
inhibitors; AP buffer (acid phosphatase buffer), 10 mM piperazine-
N,N'-bis(2-ethanesulfonic acid) (PIPES) at pH 6.0 and protease in-
hibitors; CIP buffer (calf intestinal alkaline phosphatase buffer), 50
mM Tris-HCl at pH 8.0, 25 mM NaCl, 5 mM MgCl2, and protease
inhibitors; protease inhibitors, 1 mM phenylmethylsulfonyl fluoride,
1 mM benzamidine, 10 jig/ml pepstatin A, 10 Ag/ml leupeptin, and
10 Ag/ml soybean trypsin inhibitor; phosphatase inhibitors, 10 mM
sodium azide, 10 mM sodium fluoride, 10 mM sodium molybdate,
10 mM sodium pyrophosphate, 10 mM potassium phosphate, 1 mM
EDTA, and 1 mM EGTA. Okadaic acid was used at 5 MM.
Antibodies
The production of polyclonal Cdc7 antibody is described in Yoon and
Campbell (1991). To purify the Cdc7 antibody, an affinity column
was made by linking 5 mg of bacterially produced Cdc7 protein to 1
g of CNBr-activated Sepharose as recommended by Pharmacia (Pis-
cataway, NJ). By using this Cdc7 affinity column, the antibody was
purified according to the method detailed in Harlow and Lane (1988).
The monoclonal antibody 12-CA5, a subclone of H26D08 (mouse
IgG 2b), was raised against the influenza hemagglutinin peptide (HA;
YPYDVPDYA) as previously described by Field et al. (1988). The hy-
bridoma was kindly provided by D.J. Anderson (California Institute
of Technology) and was cultured in the Caltech Monoclonal Antibody
Facility. The anti-HA peptide antibody was purified from ascites fluid
by using a protein A-Sepharose column according to manufacturer's
instructions (Sigma, St. Louis, MO). Antibodies to the 11 N-terminal
amino acids of Cdc28 as well as the N-terminal peptide immunogen
were the gift of M. Tyers and A.B. Futcher, Cold Spring Harbor, NY.
p13 beads were the gift of W.G. Dunphy, California Institute of Tech-
nology, Pasadena, CA.
Immunoprecipitations and Protein Kinase Assays
Either whole-cell or nuclear extracts were used to prepare immune
complexes. The amounts of extracts and antisera used are indicated
specifically in each Figure legend. Cdc7 immune complexes were pre-
pared as previously described (Yoon and Campbell, 1991). Cdc28
immune complexes were precipitated with 20 zl of protein A-Seph-
arose beads (100 mg/ml; Sigma), washed four times in IP buffer,
twice in K buffer, and resuspended in 25 ul of K buffer. After 5 min
preincubation at 25 or 38°C, 0.1 mM ATP, 10 ,Ci [,y-32P]ATP (3000
Ci/mmol; Amersham [Arlington Heights, IL] PB10168) and substrate
were added to a final vol of 36 ztl. Incubation was continued at the
same temperature for 20 min and reaction products were analyzed
on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels.
Purification of HA-Cdc7 Fusion Protein From E. coli
Because we had previously shown that the N-terminal 20 amino acids
were dispensable for CDC7 function in vivo (Yoon and Campbell,
1991), we chose to add the hemagglutinin epitope (HA) to the N-
terminus of the Cdc7 protein. Plasmid pTHA-CDC7 encoding the
hemagglutinin epitope-Cdc7 fusion protein, called HA-Cdc7 in the
text, was constructed from the plasmid pT7-CDC7. pT7-CDC7 carries
the complete CDC7 gene cloned into the T7 promoter based vector
pT7-7 and has a unique Nde I site which marks the initiation codon
for CDC7. To construct pTHA-CDC7, the synthetic oligonucleotide 5'-
T ATG TAC CCA TAC GAT GTT CCA GAT TAC GCT AGC TTG
GGT GGT CC-3' encoding the HA epitope, YPYDVPDYA, and the
linker sequence, SLGGP, was inserted into the Nde I site of pT7-
CDC7. The linker GGP is used to connect the HA peptide to the CDC7
gene because it is expected to cause the HA peptide to protrude from
the rest of the protein. Then, the junction sites of recombinant clones
were sequenced to confirm the cloning procedures yielded an in-frame
fusion gene.
For expression of the HA-Cdc7 fusion protein in E. coli, pTHA-
CDC7 was transformed into the bacterial strain BL21 (DE3) (Studier
and Moffat, 1986). This strain carries the T7 RNA polymerase gene
under the control of the lacUV5 promoter. Cells carrying pTHA-CDC7
were grown in 500 ml of LB medium supplemented with ampicillin
(50 jig/ml) to an optical density (OD600) of 0.5. The polymerase, and
hence the HA-CDC7 fusion gene, were induced by the addition of
isopropyl ,B-D-thiogalactoside (IPTG) to a final concentration of 0.5
mM, and the culture was allowed to grow for another 3 h. Cells were
harvested, resuspended in 20 ml of ice-cold 10 mM Tris-HCl at pH
7.4, 100 mM NaCl, 1 mM MgCl2, 10 gg/ml lysozyme, protease in-
hibitors, and disrupted by sonication with four 30-s pulses. The in-
clusion bodies containing the insoluble HA-Cdc7 fusion protein were
isolated by centrifuging the bacterial extracts at 10 000 rpm for 10
min at 4°C in a Sorvall (Newton, CT) SS34 rotor. The pellet was
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resuspended in 200 mM Tris-HCl at pH 8.2, 500 mM NaCl, 0.1%
Triton X-100 (Triton Diagnostics, Alameda, CA), 1 mM dithiothreitol,
sonicated once for 30 s, and centrifuged again at 10 000 rpm for 10
min. The final pellet was dissolved in 50 ml of buffer A (25 mM Tris-
HCI at pH 8.0, 1 mM dithiothreitol, and 6 M urea).
To purify HA-Cdc7 fusion protein, protein extracts were loaded
onto 20 ml of DEAE-Cellulose (Whatman, Clifton, NJ) column that
had been equilibrated with buffer A containing 25 mM NaCl. After
washing the column with two column volume of buffer A with 50
mM NaCl, proteins were eluted by a linear gradient of 50-500 mM
NaCl in buffer A. The HA-Cdc7 fusion protein was eluted at -250
mM NaCl, as determined by protein blotting of the fractions with
Cdc7 antibody. The fractions containing the fusion protein were
pooled, diluted to a protein concentration of -50 ng/,ul with buffer
B (200mM Tris-HCl at pH 8.0,500mM NaCl, and 1 mM dithiothreitol)
containing 6 M urea, and dialyzed against buffer B with 4 M urea for
more than 8 h. The concentration of urea in the dialysis buffer was
gradually reduced from 4 M to 2 M, 1 M, and finally 0 M. The length
of dialysis in each urea concentration was for more than 8 h each.
The fusion protein was judged to be >90% pure by Coomassie blue
staining following SDS-polyacrylamide gel electrophoresis.
Expression of HA-CDC7 Fusion Gene in Yeast
To produce HA-Cdc7 fusion protein in yeast, pTHA-CDC7 was first
digested with Nde I and Sph I. The 1.8-kb DNA containing the HA-
CDC7 fusion gene was then treated with T4 DNA polymerase, EcoRI
linkers were attached, and the fragment was ligated into the EcoRI
site of the yeast expression vector, pSEY18-Gal. The resulting plasmid,
pSYCHA7, carries HA-CDC7 gene under the control of the inducible
GAL1,10 promoter and is capable of efficiently suppressing the tem-
perature sensitive phenotype of a cdc7-1 allele at the nonpermissive
temperature, 36°C. Thus the epitope does not seem to interfere with
Cdc7 function in vivo when fused to the Cdc7 protein.
Cloning of the cdc7-1 Allele and Overproduction of
Thermolabile cdc7-1 Protein in Yeast
The mutation in cdc7-1 has been shown to be a Gly to Ala change at
amino acid position 384, between the Sac I and Sph I sites (Patterson
et al., 1986; Hollingsworth et al., 1992). The polymerase chain reaction
was performed in a Perkin Elmer Cetus (Norwalk, CT) DNA Thermal
Cycler by using - 150 ng of yeast genomic DNA isolated from strain
cdc7-1 and 5 ,tg each of the oligonucleotide primers (5' primer, 5'-TAT
AAT GAG CTC AAC CTG CTG TAC ATA ATG ACG-3', where the
Sac I site is underlined; 3' primer, 5'-CTT AAG CGC ATG CCA CCA
ATT ATG CTA AAC CGT-3' in which the Sph I site is underlined).
The plasmid containing the temperature sensitive allele, pSYC7-158,
was constructed by ligation of the 1,393 bp Sac I/Sph I PCR fragment
of the cdc7-1 allele into the Sac I and Sph I sites of plasmid pSYC758,
which expresses wild-type Cdc7 protein from the GALIO promoter
(Yoon and Campbell, 1991). This creates an in-frame fusion of the
3'-1,393 bp of the cdc7-1 allele to the 5'-282 bp of the CDC7 gene.
Clones were transformed into a heterozygous diploid, CDC7/
cdc7::Tn3, carrying a disrupted cdc7 allele, which was constructed for
this test. After sporulation, the spores containing plasmids and dis-
ruptions grew but were temperature sensitive. Thus the clone com-
plements a gene disruption and gives a temperature sensitive phe-
notype. As expected, the clone does not complement cdc7-1 strains
at 36°C. Protein extracts were prepared from a cdc7-1 strain containing
either pSYC758 (wild-type CDC7) or pSYC7-158 (ts cdc7-1). Immu-
noblot analysis of these extracts confirmed that the cdc7-1 protein
was overproduced at the permissive temperature at the same levels
as wild type (unpublished observation).
Site-Directed Mutagenesis of CDC7
Oligonucleotide-mediated, site directed mutagenesis of CDC7 was
performed by means of the Amersham kit (Amersham, Arlington
Heights, IL), used according to the manufacturer's instructions. All
mutagenesis was verified by sequencing of the complete open reading
frame. The oligonucleotide GTTACCTCGGCACCGCAAAGA was
used to mutate Ser 83 to Ala. The gene was cloned into pSEY18-Gal
for expression in yeast. The resulting mutant protein was designated
Cdc7-Ala 83.
RESULTS
The Activity of Cdc7 Kinase Varies in the Cell Cycle
and is Dependent on Passage Through START
Demonstration by Sclafani et al. (1988) that CDC7 is
not periodically transcribed and that there appears to
be sufficient Cdc7 in the cell to support eight cell cycles,
indirectly suggested that fluctuation in abundance of
Cdc7 does not account for its periodic activity. To di-
rectly investigate the levels of Cdc7 protein and Cdc7
kinase activity at different stages of the cell cycle, the
activity and abundance of Cdc7 were determined in
extracts of synchronized cells. A standard a-factor block
and release protocol was followed. As shown in Figure
1, Cdc7 activity, as measured by ability of Cdc7 immune
complexes to phosphorylate histone Hi, is low in a-
factor arrested cells. Sixty minutes after removal of a-
factor, Cdc7 kinase activity increases, at the same time
as small buds appear. (The subsequent decrease in the
80' sample is probably due to poor recovery in the im-
munoprecipitate, because the level is still two- to three-
fold higher than the 40' point.) Cdc7 activity remains
high throughout the rest of the cell cycle. Activity then
drops sharply, at a position when cells with large buds
are maximal, near the end of the first cell cycle. In the
second cell cycle after release from a-factor, activity
rises again late in Gl. Thus Cdc7 activity varies in the
second cell cycle with a timing consistent with its func-
tion in late G1. The first cell cycle is also consistent, but
the first cell cycle after a-factor release is known to be
atypical, in that cells must first recover from a-factor
and then enter the cycle, a process that can be affected
by physiology of the cells. The second cell cycle is a
better indicator of cell cycle timing if good synchrony
is achieved.
The second important point demonstrated in Figure
1 is that the variations in activity levels are clearly not
determined by variations in the abundance of Cdc7
protein, because the levels of Cdc7 protein, as measured
by Western blotting, remain constant in all samples
(Figure 1).
To precisely define the timing of Cdc7 kinase ap-
pearance, we measured Cdc7 kinase activity in immu-
noprecipitates of nuclear extracts of cells arrested at
various stages in the cell cycle either by use of cdc mu-
tants or by the use of cell cycle specific inhibitors. Yeast
cells were blocked with the mating pheromone a-factor,
hydroxyurea, or nocodazole, which inhibit START,
DNA synthesis and mitosis, respectively. In addition,
cells were arrested at the cdc28, cdc4, and poll steps,
which represent START, G1, and S phase, respectively.
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Figure 1. The activity of Cdc7 kinase accumulates periodically during
the cell cycle. Strain G1906c barl carrying the CDC7-overproducing
plasmid, pSYC758, was grown at 30°C in 2 liters of 2% raffinose
synthetic complete (SC) medium (minus uracil). At A595 = 0.5, cells
were treated with 2% galactose and synchronized in Gi with 300
ng/ml a-factor for 7 h. Cells were washed twice with fresh SC medium
(minus uracil) containing both 2% raffinose and 2% galactose, and
resuspended in 1.5 liters of the same medium to release cells from
mating pheromone arrest. Samples (50 ml) were taken at 20-min in-
tervals for 400 min. Cells were harvested and resuspended in C buffer.
Whole yeast lysates were prepared from each sample by vortexing in
the presence of glass beads and clarified by centrifugation. The su-
pematants, which contain no detectable Cdc7 protein, were discarded
and the pellets were resuspended in L buffer, incubated for 30 min
on ice, and centrifuged twice to remove insoluble materials. Protein
extracts were analyzed by immunoblotting for Cdc7 quantitation and
by histone Hi kinase assay for Cdc7 activity. Protein (40 Mg each)
blots were stained with Cdc7 antibody (1:250 dilution) and the BioRad
ImmunBlot assay kit (goat anti-rabbit IgG alkaline phosphatase con-
jugate). For histone Hi kinase assay, Cdc7 immune complexes were
prepared as described in MATERIALS AND METHODS with 120 ,g
of protein and 20 ,l of Cdc7 antibody. The reaction was carried out
at 38°C for 20 min with 5 Mg of histone Hi, and the products were
visualized by autoradiography after separation on 10% SDS-poly-
acrylamide gels. For parameters of cell cycle synchrony, samples taken
at each time point were fixed with 3.7% formaldehyde and scored
for cell morphology by phase-contrast microscopy. Symbols: A, un-
budded cells; l, cells with small buds; 0, cells with large buds.
As shown in Figure 2, there was no active Cdc7 kinase
in cdc28 blocked cells and greatly reduced, though de-
tectable, levels in a-factor arrested cells (Figure 2, lanes
2 and 6). Protein levels were not significantly reduced
(unpublished observation but see Figures 1 and 3B for
Western blots of a-factor blocked cells and cdc28
blocked cells, respectively).
In contrast, cells blocked at the cdc4 step and beyond
in the cycle, even the nocodazole treated cells, contained
active Cdc7 kinase (Figure 2, lanes 3, 4, 7, and 8). When
cdc28 cells were grown at the permissive temperature,
25°C, and assayed for kinase activity, normal levels of
kinase were observed as shown in Figure 2, lane 5. These
findings suggest that the Cdc7 kinase is inactive before
START but that passage through START provides a ki-
nase active at least in vitro. Because substrate was pro-
vided in the in vitro assay, availability of substrate could
not account for the inactivity of Cdc7 in the extracts,
although such secondary factors may contribute to the
overall regulation of Gl in vivo. Thus we favored the
interpretation that activation of the Cdc7 kinase through
posttranslational modification during the cycle was an
important component of its cell cycle regulation, and
sought more direct evidence that this might be the case.
Timing of Activation of the Histone Hi
Phosphorylating Activity of Cdc7 Protein Coincides
with Increases in in vivo Phosphorylation Levels
We have previously reported that Cdc7 is a phospho-
protein and that this phosphorylation can be detected
by in vivo 32Pi labeling of cells expressing elevated levels
of Cdc7 protein (Yoon and Campbell, 1991). To deter-
mine whether the absence of Cdc7 kinase activity co-
incides with absence of phosphorylation, we carried out
blocking experiments similar to those in Figure 2 and
characterized the phosphorylation state of Cdc7 during
the block. cdc28, cdc4, cdc6, and poll strains were trans-
formed with a plasmid expressing CDC7 under control
of the GAL1,1O promoter and were labeled with 32p; in
vivo during a block at the nonpermissive temperature.
[cdc6 arrests late in Gi with a phenotype similar to cdc7
(Hartwell, 1976).] As shown in Figure 3, Cdc7 was
present as a phosphoprotein in all blocked cells (lanes
2-5). In cdc28 mutant cells, however, the amount of
phosphoprotein was barely detectable in cells held at
37°C as compared with cdc28 grown at 25°C (Figure 3,
38' 5.' U 8
aF HU NC cdc28 cdc4 poll
1 2 3 4 5 6 7 8
Figure 2. Cdc7 kinase activity in cells arrested at various points in
the cell cycle by cdc mutations or inhibitors. cdc strains (cdc28-13,
cdc4-1, and poll-17) were grown at 25°C and a barl strain at 30°C
in YPD media. At OD595 = 0.7, cdc strains were shifted to 38°C and
held there until -90% of the cells were arrested with the appropriate
terminal phenotype (lanes 6-8). barl cells were treated with a-factor
(aF; 300 ng/ml final concentration), hydroxyurea (HU; 0.2 M final
concentration), or nocodazole (NC; 20 ytg/ml final concentration) for
4 h at 30°C (lanes 2-4). Nuclear protein extracts (500 ,ug) prepared
from these strains were immunoprecipitated with affinity purified Cdc7
antibody (20 lI) and assayed for histone Hi kinase activity. The re-
action was carried out at 38°C for 20 min with 5 Mig of histone Hi.
As a control, histone Hi was incubated in the absence of Cdc7 immune
complexes (lane 1). For the cdc28-13 strain, nuclear extracts were also
prepared from cells grown constantly at 25°C and tested for the histone
Hi kinase activity at 25°C for 20 min (lane 5). The reaction products
were visualized by autoradiography after separation on SDS-poly-
acrylamide gels.
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tivity during the cell cycle even when Cdc7 is overpro-
duced (Figure 1) and the viability of cells overproducing
Cdc7 (Yoon and Campbell, 1991).
To verify that the reduction in level of phosphorylated
protein in the cdc28-arrested cells was not due to re-
duction in the amount of Cdc7 protein per se, an in-
dependent labeling and immunoprecipitation experi-
ment was carried out in conjunction with a protein blot
of the respective extracts. As shown in protein blot in
Figure 3B, there is no difference in the abundance of
the Cdc7 protein in cdc28 cells held at 360 or 25°C.
CDC7
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23°C 37°C
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Figure 3. (A) Labeling of Cdc7 protein with 32Pi in cells arrested at
different points in the cell cycle. Yeast strains (cdc28-13, cdc4-1, cdc6-
1, poll-1 7, and wild type) carrying the CDC7-overproducing plasmid,
pSYC758, were grown at 25°C in 20 ml of LPSM medium. Both 2%
raffinose and 2% galactose were used as a carbon source. At OD595
= 0.5, the temperature was shifted to 38°C for 3 h. Cells were then
labeled with 0.7-1.0 mCi of 32p; for 2 h at 38°C (lanes 2-6). For the
cdc28-13 strain, cells grown constantly at 25°C were also labeled with
32p; for 2 h at 25°C (lane 1). Whole yeast lysates were prepared as
described in the legend to Figure 1. Proteins were immunoprecipitated
with affinity purified Cdc7 antibody (20 jil) and analyzed by electro-
phoresis in a 10% SDS-polyacrylamide gel. The gel was run until the
30-kDa colored marker reached the bottom. (B) Comparison of phos-
phorylation states and abundance of Cdc7 protein in growing cells
and cells blocked by a cdc28 mutation. Phosphate labeling. 32p; labeling
of strain cdc28 carrying the Cdc7 overproducing plasmid pSYC758
was carried out as described in the legend to Figure 3A, except phos-
phate depleted YPD with 2% galactose as carbon source (Moll et al.,
1991) was used as the growth medium, because the 32p; labeling was
found to be more efficient with the Pi depleted YPD. At A600 = 0.5,
one-half of the culture was shifted to 37°C for 2 h. Cells were then
labeled with 0.5 mCi of 32Pi/ml of growth medium for 2 h at either
the restrictive 370 or at 25°C. Protein blot. Approximately 0.5 mg of
the cellular extracts used in (A) was blotted onto nitrocellulose for
the protein blots and probed with Cdc7 serum which had not been
affinity purified.
lanes 1 and 2). Thus there is a positive correlation be-
tween when the kinase is active and the phosphoryla-
tion state of Cdc7 protein (Figures 2 and 3). These results
also show that the kinase that phosphorylates Cdc7 is
not limiting and can phosphorylate the Cdc7 protein
present in cells expressing elevated levels of Cdc7 pro-
tein. This is consistent with the fluctuation in Cdc7 ac-
In Vitro Dephosphorylation of Cdc7 Protein Reduces
Histone Hi Kinase Activity to pre-START Levels
The positive correlation between the extracts in which
Cdc7 protein is maximally phosphorylated and in which
it is active predicted that phosphorylation might be es-
sential for activity of the Cdc7 kinase. The histone Hi
kinase activity of Cdc7 was therefore monitored after
incubating Cdc7 immune complexes in the presence or
absence of phosphatase (Figure 4A). For these experi-
ments we used immune complexes prepared from cells
overproducing native Cdc7 protein by incubation with
Cdc7 antibody (Figure 4A, lanes 1-3). We also prepared
a Cdc7-hemagglutinin fusion protein and overproduced
it in yeast as described in MATERIALS AND METH-
ODS. Cdc7-containing immune complexes were then
prepared with the hemagglutinin monoclonal antibody,
12-CA5, which recognizes the hemagglutinin epitope
(Figure 4A, lanes 4-7). The Cdc7 protein immunopre-
cipitated by the two antibodies was active as a histone
Hi kinase (Figure 4A, lanes 1 and 4). Upon phosphatase
treatment, however, Cdc7 was inactivated as a kinase,
as shown in Figure 4A, lanes 2, 3, and 5. The amount
of Cdc7 protein remained constant under the conditions
of the phosphatase treatment (Figure 4B), assuring that
the inactivation was not due to proteolysis. Although
phosphatase was removed by extensive washing before
assaying for kinase, two experiments were performed
to ensure that there was no residual phosphatase bound
tightly to the protein A-Sepharose beads, which might
interfere with the Cdc7 kinase. In Figure 4A, lane 6, a
combined sample of both phosphatase-treated (1/2) and
untreated (1/2) immune complexes is seen to contain
about one-half of the kinase activity of that shown in
Figure 4A, lane 4, confirming that phosphatase was not
dephosphorylating histone Hi during the kinase reac-
tion. In a separate experiment, okadaic acid was added
to the kinase reaction following phosphatase removal
to inhibit any residual phosphatase. Again, the Cdc7
kinase remained inactive (Figure 4A, lane 7). Thus we
conclude that the absence of histone Hi kinase activity
in the phosphatase treated Cdc7 protein is due to re-
moval of phosphate(s) important for kinase activity.
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Figure 4. In vitro inactivation of Cdc7 kinase with phosphatase. (A)
Three separate Cdc7 immune complexes were prepared from nuclear
extracts (500 ,ug each) of Cdc7-overproducing cells with affinity pu-
rified Cdc7 antibody (20 ,ul each; lanes 1-3). After washing 4 times
in IP buffer, 2 of them were washed twice in CIP buffer and incubated
for 15 min at 37°C in the presence (+) or absence (-) of 3 U of CIP
(lanes 1 and 2). The third immune complex was treated with 3 U of
AP after washing twice in AP buffer (lane 3). Each immune complex
was then washed 3 times in IP buffer and twice in K buffer, and
assayed for histone Hi kinase activity (15 min at 37°C) (lanes 1-3).
Whole cell lysates were prepared from cells overproducing the hem-
agglutinin-Cdc7 fusion protein (HA-Cdc7). Extracts were made from
cells (1 1) harvested at OD595 = 2 by extensive manual grinding under
liquid nitrogen as described by Schultz et al. (1991). The powder of
broken cells were resuspended in L buffer and centrifuged at 20 000
rpm for 30 min. The supernatant was frozen in aliquots at -70°C
until needed. The monoclonal antibody 12-CA5 (20 Al each) was used
to immunoprecipitate HA-Cdc7 fusion protein from these extracts
(400 ug each; lanes 4-7). Immune complexes were washed as above
and incubated with (+) or without (-) 3 U of AP before assay for Hi
kinase activity (lanes 4 and 5). In lane 6, immune complexes of AP-
treated (1/2) and untreated (1/2) samples were combined and tested
for kinase activity. Lane 7 contained immune complexes treated in
the same way as those in lane 5 except okadaic acid (5 MM) was added
in the kinase reaction. Reaction products were analyzed on an
SDS-polyacrylamide gel, stained with Coomassie blue, dried, and au-
toradiographed. (B) Three separate Cdc7 immune complexes were
prepared from Cdc7-overproducing cells with affinity purified Cdc7
antibody. After washing 4 times in IP buffer, 2 samples were washed
twice in CIP buffer and incubated for 15 min at 37'C in the presence
(+) or absence (-) of 3U of CIP (lanes 1 and 2). The third immune
complex was treated with 3U of AP after washing twice in AP buffer
(lane 3). Each immune complex was then subjected to immunoblot
analysis as described in the legend to Figure 1.
Two-Dimensional Peptide Map Analysis of
Phosphate-Labeled Cdc7 Kinase
To investigate how many phosphorylation events are
involved in the regulation of Cdc7 kinase, we first ad-
dressed the question of how many phosphopeptides
are found in Cdc7 protein isolated from an asynchro-
nously growing population. Cdc7 protein was labeled
with 32P as described in MATERIALS AND METHODS,
and purified by immunoprecipitation with affinity pu-
rified Cdc7 antibody. The Cdc7 protein was digested
with trypsin and phosphopeptides were analyzed by
two-dimensional electrophoresis and ascending chro-
matography. The protein shows four major labeled
peptides (Figure 5A). This suggests that there are mul-
tiple phosphorylation sites on the Cdc7 protein and that
the regulation may, therefore, be complex.
Autophosphorylation Contributes to the
Phosphorylation Pattern of Cdc7 Protein
At least one of the phosphoamino acids in Cdc7 appears
to be due to autophosphorylation. We have previously
shown that Cdc7 protein itself becomes labeled when
Cdc7 immunoprecipitates are incubated with [-y-
32P]ATP, suggesting that Cdc7 kinase might autophos-
phorylate (Yoon and Campbell, 1991). To ask if the
phosphorylation is due to Cdc7 kinase or to a coim-
munoprecipitating kinase, the thermolabile cdc7-1 mu-
tant protein was assayed for autophosphorylation. We
and others have previously shown that the catalytic ac-
tivity of the mutant Cdc7 kinase is thermolabile in vitro
(Hollingsworth and Sclafani, 1990; Yoon and Campbell,
1991). As shown in Figure 6, the cdc7-1 protein in yeast
immunoprecipitates became phosphorylated when in-
cubated with the ATP substrate at 25°C but not when
incubated at 38°C. Because the kinase activity is ther-
molabile, it is most likely due to Cdc7 kinase itself and
not to a contaminating kinase, which one would expect
to have higher activity at 38°C. We have not yet de-
termined the phosphopeptide map of this site, because
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Figure 5. Tryptic phosphopeptide map of Cdc7 protein and Cdc7-
Ala 83. Wild-type cells (20 ml), carrying either pSYC758 (wild-type
Cdc7) or pSYC 7-83 (mutant Cdc7) were labeled as described in the
legend to Figure 3B for 2 h when the A600 reached 0.5. After labeling,
the cells pellets were resuspended in 1 ml of ice-cold buffer (50 mM
Tris, pH 7.4, 0.5% Triton X-100, 0.5% sodium deoxycholate, 0.1%
SDS, 1 MiM okadaic acid, 1 AM PMSF). One volume of glass beads
was added and the cells lysed by vortexing at 4°C for 2 min. After
clarifying the lysates by centrifugation, the lysates were treated with
50 Mg/ml each of DNase and RNase A. Immunoprecipitation of the
Cdc7 protein was carried out with 150 ,ul of Cdc7 antibody and 20
,ul of protein A Sepharose beads (100 mg/ml). The beads were then
washed 3 times with IP buffer (50 mM Tris, pH 7.4, 150 mM NaCl,
0.2% Tween 20, 0.5 mM EDTA) and boiled for 5 min in SDS gel
loading buffer. Proteins were separated on a 10% SDS-polyacrylamide
gel and transferred to nitrocellulose. Tryptic phosphopeptides of Cdc7
were prepared and resolved by electrophoresis at pH 1.9 followed by
ascending chromatography with phosphochromatography buffer on
thin layer cellulose plates as described by Boyle et al. (1991). Left:
Wild-type Cdc7 protein. Right: Mutant Cdc7-Ala 83 protein. Oligo-
nucleotide mediated site-directed mutagenesis of CDC7 was carried
out as described in MATERIALS AND METHODS.
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Figure 6. Cdc7 protein autophosphorylates.
Plasmid pSYC7-158, containing the mutant
cdc7-1 allele, was prepared as described in
MATERIALS AND METHODS. Strain cdc7-
1 carrying pSYC7-158 was used to prepare
nuclear extracts. Extracts were immunopre-
cipitated with Cdc7 antibody as described in
MATERIALS AND METHODS. Protein ki-
nase assays were carried out as described in
Figure 2, except that no histone Hi was added
to the reaction mixture. Reaction mixtures
were incubated at either 25 or 38°C as indi-
cated in the figure.
had to be purified so that it could be used as a substrate.
Cdc7 protein was expressed in E. coli as a fusion protein
with the hemagglutinin epitope (see MATERIALS AND
METHODS for details). Although a number of different
conditions were tested, the bacterially produced fusion
protein, designated HA-Cdc7 protein, was not active as
a kinase, in contrast to that produced in yeast (see Figure
8). In addition, Cdc7 protein expressed in E. coli is not
phosphorylated (Yoon, Loo, and Campbell, our unpub-
lished data). The unphosphorylated Cdc7 protein was
therefore ideally useful as a substrate to test the effects
of phosphorylation by Cdc28 immune complexes.
Antibodies raised against the N-terminal 11 amino
acids of Cdc28 protein (gift of M. Tyers and A.B.
Futcher, Cold Spring Harbor, NY) were used to prepare
Cdc28 immune complexes. As shown in Figure 7, the
Cdc7 fusion protein was phosphorylated by the Cdc28
immune complexes. Two controls were performed to
ask if Cdc28 was responsible for the phosphorylation.
First, extracts from a wild-type strain and from strain
cdc28-13, extracts of which contain a thermolabile Cdc28
kinase (Reed et al., 1985; Wittenberg and Reed, 1988),
were compared as a source of Cdc28 kinase. The protein
kinase reaction was carried out at the permissive (25°C)
and nonpermissive temperature (38°C) for the cdc28-
the amount of incorporated label is limiting and varies
from experiment to experiment, perhaps due to differing
levels of phosphate on the endogenous protein in ex-
tracts prepared for different experiments.
A Protein Kinase in Yeast Extracts can
Phosphorylate Cdc7 Protein In Vitro
Because of the complex phosphorylation pattern of Cdc7
protein from asynchronous cells, we expect that more
than one protein kinase contributes to the phosphory-
lation pattern. Because Cdc7 autophosphorylates, we
could not easily interpret assays of yeast crude extracts
for activities that phosphorylate Cdc7. Instead, we have
initially focused on phosphorylation by a single kinase
in yeast extracts, the Cdc28 kinase, because a number
of previous findings pointed to a possible role for this
enzyme. It seemed reasonable that the Cdc28 kinase or
a kinase with a similar specificity might phosphorylate
Cdc7, because Cdc7 carries the consensus recognition
sequence for Cdc28 kinase at amino acids 83-86. Fur-
thermore, the inactivity of Cdc7 kinase and its hypo-
phosphorylation in cdc28-arrested extracts were consis-
tent with the Cdc7 protein being a substrate of the
Cdc28 kinase. The recent demonstration that Cdc28 ki-
nase is active late in Gl, that is during a cdc7 block
(Moll et al., 1991), when it might be needed to activate
Cdc7, was a further argument that made it reasonable
to test if Cdc7 was a biochemical (or in vitro) substrate
of Cdc28 kinase. To directly test this, the Cdc7 protein
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Figure 7. Phosphorylation of Cdc7 protein by Cdc28 immune com-
plexes. Whole yeast lysates were prepared from a cdc28-13 strain and
a wild-type strain as described in the legend to Figure 4. Cdc28 kinase
was then immunoprecipitated from these extracts (100 ,ug each) with
excess antibody (2 pl each) raised against the N-terminal 11 amino
acids of Cdc28 protein (lanes 1-4 and 7-10) or with the same antibody
preincubated with 30 qg of the N-terminal peptide (lanes 5, 6, 11,
and 12). Cdc28 immune complexes were prepared from cdc28-13 strain
in lanes 1-6 and from wild-type strain in lanes 7-12. Kinase reactions
were carried out at 25°C (lanes 1, 3, 5, 7, 9, and 11) or 38°C (lanes
2, 4, 6, 8, 10, and 12) with 500 ng of HA-Cdc7 fusion protein as
substrate. The fusion protein was purified out of E. coli cells as ex-
plained in MATERIALS AND METHODS. In lanes 3, 4, 9, and 10,
Cdc28 immune complexes were incubated in the absence of the fusion
protein. Products were analyzed by electrophoresis on a 10% SDS-
polyacrylamide gels, which were run until the 30-kDa marker protein
reached the bottom. The HA-CDC7 band was identified by staining
of the gels with Coomassie blue. The 500 ng of HA-Cdc7 fusion
protein was the major band and was absent where HA-Cdc7 was
omitted from the experiment. Lanes 1-6 were run on one gel and
lanes 7-12 on another gel. The experiments with the cdc28-13 extract
were repeated 4 times.
Molecular Biology of the Cell
CDC7
202
A.
HA Cd c 7--im-- is 11-1111'
Control of the Gl/S Transition
13 mutation. Comparison of lanes 1 and 2 in Figure 7
demonstrates that there was less Cdc7 phosphorylating
activity in the immune complexes prepared from strain
cdc28-13 at 38°C than at 25°C. In contrast, immune
complexes from the wild-type strain, while less active
overall, were more active at 38°C than at 25°C (lanes
7 and 8). As a second control, the 11 amino acid, Cdc28-
derived peptide employed as immunogen was used as
competitor in the immunoprecipitation. Cdc7 was not
phosphorylated when the Cdc28 antibody was prein-
cubated with the Cdc28-peptide (Figure 7, lanes 5, 6,
11, and 12). Thus the in vitro phosphorylation is likely
due to the Cdc28 protein.
Additional proteins were phosphorylated by the
Cdc28 immune complexes as shown in Figure 7. None
of these proteins appeared to be phosphorylated in a
Cdc28-specific way, because the level of phosphory-
lation was the same at either temperature or the kinase
activity was thermolabile even in the wild-type strain.
However, the -62 kDa band present above the HA-
Cdc7 protein could represent a coprecipitating cyclin.
Similar results to those shown in Figure 7 have been
obtained by using p13 beads (gift of W.G. Dunphy;
Dunphy and Newport, 1989) and Cksl antibodies (gift
of C. Wittenberg) (unpublished observation) to prepare
the Cdc28 kinase. CKS1 encodes the S. cerevisiae p13
analog and Cksl antibodies have been shown to coim-
munoprecipitate active Cdc28 kinase along with Cksl
protein (Hadwiger et al., 1989a). Because the enzymo-
logical specificity of Cdc28 present in Cdc28 kinases
prepared with these different reagents has not been
characterized, we cannot yet derive any information
about which of the postulated forms of Cdc28 kinase
is active in our experiments.
The phosphorylation by Cdc28 in vitro is not efficient
enough currently to allow mapping of the peptide(s)
directly phosphorylated by the Cdc28-like activity. This
appears to be due to difficulty and lack of reproducibility
in refolding the protein purified from E. coli (see MA-
TERIALS AND METHODS). We have been unable to
increase the level of phosphorylation of HA-Cdc7 fusion
protein as compared with that of other proteins, due to
difficulties thus far in obtaining concentrated HA-Cdc7
protein in soluble form. The fusion protein precipitates
at concentrations >50 ng/,l under reaction conditions
tested thus far. Although we have not been able to
achieve the sensitivity necessary to carry out phospho-
peptide analysis of the Cdc7 protein phosphorylated in
vitro, an alternative approach to gaining information
about the amino acid site phosphorylated by the Cdc28
immunoprecipitates is provided by the ability to express
a mutant Cdc7 protein with an altered Cdc28 consensus
recognition site in yeast. A two-dimensional phospho-
tryptic peptide map of Cdc7 protein containing a mu-
tation of Ser 83 to Ala, in the putative Cdc28 consensus
recognition site, is shown in Figure 5B. Comparison to
the wild-type protein in Figure 5A shows that there is
a major alteration in the phosphorylation pattern; two
spots are greatly reduced in intensity and a third spot
is missing. Protein blotting verifies that the amount of
mutant protein in extracts is identical to that of wild
type (Loo and Campbell, unpublished observations).
Thus the in vivo pattern suggests that alteration of the
consensus site for Cdc28 phosphorylation has a dra-
matic effect on more than one phosphorylation site on
the Cdc7 protein. We cannot make a definitive statement
about how many phosphorylation sites are affected until
we know whether the three spots in wild type arise due
to multiple, distinct phosphorylation sites or due to in-
complete typtic digestion. Further studies will be re-
quired to show if this biochemical result reflects the
physiological situation.
Phosphorylation of Cdc7 Protein by Cdc28 Activates
the Cdc7 Kinase
To test whether phosphorylation of Cdc7 by Cdc28 is
sufficient to activate the inactive bacterially produced
Cdc7 protein, we designed an experiment in which we
first phosphorylated highly purified, soluble, bacterially
produced HA-Cdc7 protein with cold ATP with Cdc28
immune complexes from crude yeast extracts. We then
removed the Cdc28 kinase and assayed the ability of
the Cdc7 kinase to phosphorylate histone Hi. To insure
that Cdc28 could not participate in the histone Hi
phosphorylation reaction, we used extracts prepared
from a cdc28-13 strain that is known to produce a kinase
that is thermolabile in vitro. The first reaction was car-
ried out at 23°C, where the cdc28-13 kinase is active,
and the second was carried out at 37°C, where the
cdc28-13 kinase is not active. If wild-type CDC28 extracts
were used, sufficient Cdc28 kinase activity remained in
the supernatant so that even in the control without HA-
CDC7 protein added, there was some histone Hi kinase
activity. As shown in Figure 8, HA-Cdc7 kinase pro-
duced in E. coli is active only after treatment with Cdc28
kinase (compare lanes 2 and 3). Inclusion of the Cdc28
peptide during preparation of Cdc28 immune complexes
abolished the activation (lane 3) and activation was se-
verely reduced at high temperature when cdc28-13 was
used as source of the Cdc28 protein (lane 4). Thus we
conclude that Cdc7 phosphorylation by Cdc28 can ac-
tivate the kinase activity, though potential contribution
of other components in the Cdc28 immunoprecipitates
does not allow the conclusion that Cdc28 is sufficient
to activate Cdc7. [A report, that might appear to conflict
with our findings, that Cdc7 was active as a kinase when
prepared in an in vitro translation system, in which
posttranslational modification is not expected to occur,
could be explained by the adventitious presence of a
Cdc28-like kinase in the translation kit (Bahman et al.,
1988).]
DISCUSSION
Our studies were initiated in an attempt to define the
molecular basis of the timing of Cdc7 function in the
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Figure 8. Cdc28 kinase activates Cdc7 kinase in vitro. This experi-
ment represents a 2-stage in vitro phosphorylation protocol. In stage
1, Cdc7 is phosphorylated by Cdc28 immune complexes. In stage 2,
histone Hi is phosphorylated by the Cdc7 kinase. Stage 1: Cdc28
immune complexes were prepared from strain cdc28-13 as described
in the legend to Figure 5. In lane 3, the Cdc28 antibody was prein-
cubated with 30 ,g of the Cdc28 peptide as competitor. After 5 min
at 25°C (lanes 1-3) or 38°C (lane 4), either 20 yl of HA-Cdc7 fusion
protein (50 ng/ml) in buffer B (lanes 2-4) or 20 Ail of buffer B alone
(lane 1) were added together with 1 mM ATP. Incubation was con-
tinued at the same temperature for 10 min and reaction mixtures were
centrifuged for 1 min to remove Cdc28 immunoprecipitates. Stage 2:
supematants, which contained either HA-Cdc7 protein or buffer alone,
were incubated at 38°C for 5 min to inactivate any residual cdc28-
13-dependent kinase. Then, histone Hi kinase reactions were carried
out at 38°C for 10 min with 0.1 mM ATP, 10 OCi [y_32p] ATP, and
5 jig of histone H1. Reaction products were analyzed by electrophoresis
on a 10% SDS-polyacrylamide gel.
yeast cell cycle. Demonstration that CDC7 encodes a
protein kinase (Patterson et al., 1986; Hollingsworth and
Sclafani, 1990; Yoon and Campbell, 1991) provided us
with an assay for factors that contribute to the regulation
of the Cdc7. Biochemical experiments showed that Cdc7
kinase activity fluctuates in the cell cycle with a peri-
odicity coinciding with the in vivo function of Cdc7,
but the steady-state protein levels remain constant,
suggesting that it is the kinase activity of Cdc7 that is
responsible for its essential role and that it is activation
rather than abundance that accounts for cell cycle vari-
ation. In addition, we showed that Cdc7 kinase activity
is undetectable in extracts of cells arrested before
START, either by an a-factor block or by a cdc28 mu-
tation, and found that this corresponds to a period when
the Cdc7 protein is hypophosphorylated compared with
any other point in the cell cycle. Combined with the
fact that dephosphorylation of Cdc7 in vitro reduces
the kinase activity to pre-START levels, these findings
suggest that phosphorylation plays a role in regulating
Cdc7 function. In an effort to specify the important
phosphorylation events, we then showed that there are
at least four tryptic phosphopeptides in Cdc7 protein
populations. Both autophosphorylation and phosphor-
ylation in trans by a protein in yeast extracts occur. The
ubiquitous protein kinase, Cdc28 kinase, is at least one
protein that can phosphorylate Cdc7 protein in vitro.
These observations raise many interesting questions
about the timing of multiple phosphorylations of Cdc7,
the role of individual phosphorylations and their inter-
dependence and whether Cdc7 is a substrate of the
Cdc28 kinase in vivo.
Timing of Cdc7 Function in the Cell Cycle
Early work from the Hartwell laboratory defined three
genes necessary for the initiation of DNA replication,
CDC28, CDC4, and CDC7, as discussed in the INTRO-
DUCTION. CDC28 functions at START, and after return
of cdc28 mutants from the nonpermissive temperature
the cells can still adopt the alternative pathway of con-
jugation. Several more genes that have this phenotype
have been identified but as yet have not been well stud-
ied. Three additional genes that affect START, CLN1,
2, and 3, are apparently involved in a positive feedback
loop controlling the activation of the CDC28 gene prod-
uct (Cross and Tinkelenberg, 1991; Dirick and Nasmyth,
1991). These genes were identified either as suppressors
of cdc28 mutations (CLN1, CLN2) or as dominant gain
of function mutations (CLN3) (Sudbery et al., 1980;
Cross, 1988; Nash et al., 1988; Hadwiger et al., 1989b)
and have at least partially redundant functions, in that
one CLN gene can compensate for loss of the other, but
loss of all three is lethal (Richardson et al., 1989). The
CLN genes encode proteins that are distantly related to
the cyclins that activate the p34/cdc2+/MPF kinase for
induction of mitosis in Xenopus, S. pombe and other or-
ganisms. By analogy, it has been proposed that CLN1,
2, and 3 interact with and activate the Cdc28 kinase
subunit and passage through START (Richardson et al.,
1989; Wittenberg et al., 1990; see also Cross, 1988; Nash
et al., 1988 and for review Nasmyth, 1990). The mo-
lecular nature of the events set in motion by these
START genes, however, has been more difficult to de-
fine.
Morphological analysis of single and double mutants
and reciprocal shift studies suggest CDC7 acts subse-
quent to CDC28/START (Hereford and Hartwell, 1974).
In addition to CDC4 and CDC7, three other genes,
CDC34, DBF4, and possibly DBF2 also function in the
post-START/pre-DNA synthesis period (Johnston and
Thomas, 1982; Goebl et al., 1988; Chapman and John-
ston, 1989; Johnston et al., 1990). These dependent ge-
netic relationships predicted that activation of the Cdc7
protein should be dependent on completion of START.
In keeping with this, we found that Cdc7 kinase was
inactive in extracts of cells arrested at START-either
by a-factor or by a cdc28 arrest. We then found that
after release from a block and passage through START
the kinase activity increased, decreased abruptly late in
the cell cycle, and then rose again in Gl in the second
cell cycle. This temporal correlation of appearance of
kinase activity and in vivo function adds to the argu-
ment, previously based solely on site-directed muta-
genesis (Buck et al., 1991; Hollingsworth et al., 1992),
that the kinase activity of Cdc7 is related to its essential
and periodic function.
Genetic studies predicted that Cdc7 activity might be
dependent on CDC4, also. The results in Figure 2 suggest
that, on the contrary, the Cdc7 kinase is already active
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even before CDC4 completes its function. Why does
CDC7 appear to depend upon the completion of CDC4
in vivo? One possibility is that the substrates of Cdc7
kinase may not be available during the cdc4 block. Ac-
cording to the results of Hereford and Hartwell (1974),
cdc4 mutants blocked and released in the presence of
the protein synthesis inhibitor cycloheximide do not
enter S phase. Further protein synthesis is thus necessary
after the CDC4 step. Proteins newly synthesized after
the CDC4 step may include replication proteins that re-
quire the Cdc7 kinase for posttranslational activation.
Alternatively, substrates of Cdc7 kinase may exist dur-
ing the cdc4 block, but somehow may be inaccessible
to Cdc7 protein until after CDC4 has functioned. A third
possibility is that Cdc7 kinase, like many other kinases,
actually consists of two subunits, a catalytic subunit and
a regulatory subunit whose abundance or modification
is dependent on CDC4 function. We feel that it is likely
that Cdc7 does have a regulatory subunit that enhances
activity and is encoded by a second yeast gene, since
we have recently been able to purify an active Cdc7
kinase from yeast and have found that Cdc7 copurifies
with an 80-kDa protein, though we have not yet de-
termined whether this 80-kDa protein represents an-
other substrate or an essential cofactor for Cdc7 activity
(Loo and Campbell, unpublished observations). We also
observe an 80-kDa protein in Cdc7 immunoprecipitates
from yeast (see Figure 3, Yoon and Campbell, 1991).
Genetic suppression of cdc7 by overproduction of DBF4
and vice versa could also be interpreted as indicating
that the Cdc7 kinase has a second subunit (Kitada et
al., 1992).
How is the timing of Cdc7 action controlled? One
component of the regulation seems to be phosphory-
lation of Cdc7 protein. Phosphatase treatment of Cdc7
kinase abolishes its histone Hi kinase activity (Figure
4). In addition, its phosphorylation state correlates well
in the cell cycle with the time when it is active (Figures
2 and 3). It appears likely from our studies that Cdc28
kinase provides at least one essential phosphate mod-
ification (Figures 5 and 6). We also know that Cdc7 is
phosphorylated by at least one other kinase, in that
Cdc7 appears to autophosphorylate (Figure 3 in Yoon
and Campbell, 1991; and this work Figure 6).
Possible Roles for Phosphorylation in Cdc7
Activation
Dephosphorylation of Cdc7 immune precipitates leads
to their inactivation as a kinase. This suggests that at
least one phosphoamino acid is necessary for catalytic
activity. We cannot rule out the more trivial explanation
that dephosphorylation causes dissociation of an as yet
unidentified, essential subunit. Even if the latter is the
case, however, ultimately the phosphorylation event is
essential for activation and therefore crucial. Thus we
have begun an analysis of the phosphorylation of Cdc7
protein. We have now provided strong evidence that
Cdc7 autophosphorylates. In their studies of cell cycle
phosphorylation of p34cdc2 kinase, Krek and Nigg (1991)
found that it is probably Thr 161 that is phosphorylated
in M phase and pointed out that Thr 161 is located
within a conserved domain which in other kinases is
subject to autophosphorylation (Hanks et al., 1988).
Furthermore, they referred to the fact that the cognate
amino acid, Thr 167, in S. pombe cdc2 kinase is essential
for function and is phosphorylated. The corresponding
residue in Cdc7 kinase is Thr 281, located in region VIII
of the canonical protein kinase active site (Hanks et al.,
1988). Buck et al. (1991) have shown by site-directed
mutagenesis that either a serine or a threonine at this
position is essential for the in vivo functions of CDC7.
Therefore, we predict that Thr 281 may be the site of
autophosphorylation and that phosphorylation of this
site may be required for full Cdc7 activity. We note,
however, that Xenopus p34CdC2, which requires phos-
phorylation of Thr 161 for activation, does not appear
to autophosphorylate but rather to be phosphorylated
in trans (Solomon et al., 1992).
Is CDC7 a Physiological Substrate of CDC28?
We have shown that Cdc28 immunoprecipitates can
phosphorylate and even activate the histone Hi phos-
phorylating activity of Cdc7 kinase in vitro and that
Cdc7 kinase is inactive in cells blocked by a cdc28
mutation. In keeping with our proposal that auto-
phosphorylation is necessary for activity, then phos-
phorylation by the "Cdc28" kinase may change the
conformation of Cdc7 to a state that allows autophos-
phorylation of an additional essential site. It has been
shown for several kinases that phosphorylation of one
site can influence sequential phosphorylation of other
sites (see Roach, 1991, for complete discussion of multi-
site and hierarchical protein phosphorylation). Indeed,
our phosphopeptide analysis suggests that there may
be at least four phosphoamino acids on the Cdc7 pro-
tein. Krek and Nigg (1991) have discovered four phos-
phorylation sites on mammalian p34cdc2 and have
shown that each one is cell cycle regulated: Thr 14 and
Tyr 15 are phosphorylated in G2; Thr 161, probably, is
phosphorylated in M, and Ser 277 phosphorylation
peaks in Gl. All probably contribute to the regulation
of the enzyme. Considering the multiple functions of
Cdc7, similar complex regulation is not unlikely.
Although we also favor a multisite phosphorylation
scenario for Cdc7, we by no means claim that our results
establish Cdc7 as a substrate of Cdc28 in vivo. Given
the nature of cell cycle mutants, one could argue that
the effect of the cdc28 mutation is indirect. Another in-
termediate kinase may be required or an essential co-
factor may not become available until after START. For
instance, Solomon et al. (1992) have shown that Xenopus
p34cdc2 must associate with cyclin to be phosphorylated
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on Thr 161. Therefore the reduction in phosphorylation
in the cdc28 mutant does not constitute an argument
that Cdc28 is a Cdc7 kinase in vivo. Furthermore, our
demonstration that phosphorylation of Cdc7 in vitro by
Cdc28 activates Cdc7 kinase is important, but it is in-
conclusive in the sense that it only demonstrates that
the kinase active in vivo must have the same specificity
as Cdc28. The consensus motif for a cdc2+/Cdc28
phosphorylation site has been reported to be S/T-P-X-
Z (where X is a polar amino acid, and Z is generally a
basic amino acid) (for reviews, see Lewin, 1990; Moreno
and Nurse, 1990 and Pines and Hunter, 1990). The pri-
mary amino acid sequence of CDC7 contains one such
motif, TSS83PQR, near the N-terminus, adjacent to the
ATP binding site. Mutation of Ser 83 to Ala 83 results
in a drastically altered phosphopeptide map of Cdc7
(Figure 5, this work). Furthermore, we have recently
expressed the Ala 83 Cdc7 mutant protein in the cdc7-
1 strain and found that it failed to complement the cdc7-
1 mutant for growth at the nonpermissive temperature
(Loo, Yoon and Campbell, unpublished observations).
Taken together these results are consistent with Ser 83
being the site of a crucial phosphorylation. In some
cases, even the simple sequence S/T-P is recognized by
cdc2+ kinases (see references in Roach, 1991). Cdc7
contains three SP or TP sites which lie in the C terminal
half of Cdc7. Mutations of the respective serines and
threonines in these positions have no effect on in vivo
function (Loo, Yoon, and Campbell, unpublished ob-
servations).
Recently, three criteria have been set for establishing
a protein as the physiological substrate of a particular
kinase (Lewin, 1990). First, the amino acid phosphor-
ylated by the kinase in vitro should be occupied in vivo
at the point in the cell cycle when it is needed. Second,
mutations, either in the kinase or in its recognition site
in the substrate or both, should block phosphorylation
in vivo. Third, some function of the protein should be
altered by phosphorylation. To identify the kinases that
phosphorylate Cdc7 and their sequence of action will
require much more work: mapping of specific phos-
phorylation sites, determination of function of specific
phosphorylation events by site directed mutagenesis,
evaluation of phosphopeptide maps in protein kinase
mutants and purification of the kinases responsible.
Only when all this work is done will we be able to
answer whether and or how sequential phosphorylation
influences Cdc7's various in vivo functions.
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